Symbol="EQRXW"
AssetType="Common Stock"
Name="EQRx Inc"
Description="EQRx, Inc., a pharmaceutical company, is engaged in the development of drugs primarily for the treatment of cancer and immuno-inflammatory diseases in the United States. The company is headquartered in Cambridge, Massachusetts."
CIK="1843762"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="C/O CORVEX MANAGEMENT LP, 667 MADISON AVENUE, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="None"
EBITDA="-278076992"
PERatio="None"
PEGRatio="None"
BookValue="-8.18"
DividendPerShare="None"
DividendYield="0"
EPS="-7.65"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="0"
ReturnOnEquityTTM="0"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-7.65"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="-"
EVToRevenue="-"
EVToEBITDA="-"
Beta="None"
num_52WeekHigh="1.52"
num_52WeekLow="0.103"
num_50DayMovingAverage="0"
num_200DayMovingAverage="0"
SharesOutstanding="0"
DividendDate="None"
ExDividendDate="None"
symbol="EQRXW"
open="0.14"
high="0.20"
low="0.14"
price="0.19"
volume="1234.00"
latest_trading_day="2023-07-17"
previous_close="0.20"
change="-0.00"
change_percent="-1.5897%"
aroon_positive_momentum_days="22"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="22"
Volume_recent_avg="7500"
Change_recent_avg="0.01"
Delta_recent_avg="0.02"
Variance_recent_avg="0.01"
Change_ratio_recent_avg="3.2"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="22"
Aroon_momentum_negative="78"
image_negative_thumbnail_id_1="494"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0111.jpeg"
image_negative_thumbnail_id_2="105"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0071.jpeg"
image_neutral_thumbnail_id_1="552"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_neutral_thumbnail_id_2="540"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0059.jpeg"
image_positive_thumbnail_id_1="675"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0033.jpeg"
image_positive_thumbnail_id_2="636"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0072.jpeg"
image_professor_thumbnail_id_1="1191"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
image_professor_thumbnail_id_2="1167"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
